QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, further ...

MaxCyte will host a conference call today, March 11, 2025, at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call are required to register online. A live and archived ...

Rhumbline Advisers boosted its stake in AvidXchange Holdings, Inc. (NASDAQ:AVDX – Free Report) by 1.0% in the fourth quarter, ...

Late-February 2025, 28 of the 30 “Safer” MoPay Equities were tagged “IDEAL” for dividends as they showed positive one-year ...

While electronic exchange of orders and results is commonplace in the commercial lab world, public health labs struggle with inconsistent levels of connectivity.

On June 15, 2020, Plaintiff Gelt Trading, Ltd. filed a securities class action against Co-Diagnostics, Inc. and certain of the Company's current and former directors and officers alleging violations ...

For example, non-IFRS adjusted EBITDA excludes a number of expense items that are included in net ... from our business acquisitions like our acquisition of the Oncotype DX® GPS prostate cancer ...

Q4 2024 Earnings Call Transcript February 24, 2025 Veracyte, Inc. beats earnings expectations. Reported EPS is $0.36, expectations were $0.29. Operator: Good day, and thank you for standing by.

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Daxor Corporation Conference ...

Donald Trump and Keir Starmer met in Washington, raising hopes the UK could escape tariffs the US has threatened on others.

Rhumbline Advisers increased its stake in ChromaDex Co. (NASDAQ:CDXC – Free Report) by 36.0% in the 4th quarter, according to ...